Left Atrial Remodeling Identification and Catheter Ablation Outcomes With 18 F‐Fluorodeoxyglucose Positron Emission Tomography in Persistent Atrial Fibrillation
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.041491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Tristan Raoult und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Cardiovascular Diseases Cliniques Universitaires St. Luc, Pôle de Recherche Cardiovasculaire (CARD) 10 avenue h…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Remodeling, Fluorodeoxyglucose F18, Catheter Ablation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Left atrial structural remodeling contributes to the persistence of atrial fibrillation (AF) and influences the outcomes of catheter ablation (CA). We investigated the usefulness of 18 F‐fluorodeoxyglucose‐positron emission tomography in detecting low atrial glucose uptake (LGU) as a potential marker of fibrosis and its predictive value for CA success in persistent AF.
Methods
Thirty‐six patients without diabetes with persistent AF scheduled for CA underwent nicotinic acid‐stimulated 18 F‐fluorodeoxyglucose‐positron emission tomography to assess global and segmental LGU before CA. LGU was compared with low voltage areas on electroanatomical mapping, left atrial volume index via echocardiography, and late gadolinium enhancement from cardiac magnetic resonance imaging as indicators of fibrosis. Patients were followed for up to 24 months post CA to assess AF recurrence.
Results
Global LGU extent was 16.8% (7.6–42.6) and correlated with left atrial volume index (R 2 =0.20, P =0.039) and low voltage area during AF and right atrial pacing (R 2 =0.54 and R 2 =0.35 respectively, both P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Cardiovascular Diseases Cliniques Universitaires St. Luc, Pôle de Recherche Cardiovasculaire (CARD) 10 avenue hippocrate Brussels 1200 Brussels Belgium.
- Pole Molecular Imaging, Radiotherapy & Oncology (MIRO) Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain Brussels Belgium.
ORCID-Profile: Tristan Raoult, Bernhard L Gerber, Christophe Scavée, Varnavas Varnavas, Michel Hesse, Véronique Roelants, Sébastien Marchandise
Zitieren
APA
Raoult, T., Gerber, B. L., Garnir, Q., Scavée, C., Varnavas, V., Wauters, A., Gruson, D., Nellessen, E., Hesse, M., Beauloye, C., Roelants, V., & Marchandise, S. (2025). Left Atrial Remodeling Identification and Catheter Ablation Outcomes With 18 F‐Fluorodeoxyglucose Positron Emission Tomography in Persistent Atrial Fibrillation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.041491
Vancouver
Raoult T, Gerber BL, Garnir Q, Scavée C, Varnavas V, Wauters A, et al. Left Atrial Remodeling Identification and Catheter Ablation Outcomes With 18 F‐Fluorodeoxyglucose Positron Emission Tomography in Persistent Atrial Fibrillation. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.041491
BibTeX
@article{Raoult2025,
author = {Raoult, Tristan and Gerber, Bernhard L and Garnir, Quentin and Scavée, Christophe and Varnavas, Varnavas and Wauters, Aurélien and Gruson, Damien and Nellessen, Eric and Hesse, Michel and Beauloye, Christophe and Roelants, Véronique and Marchandise, Sébastien},
title = {Left Atrial Remodeling Identification and Catheter Ablation Outcomes With 18 F‐Fluorodeoxyglucose Positron Emission Tomography in Persistent Atrial Fibrillation},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.041491}
}
EUVIMED